​AIM Specialty Health^® (AIM) has updated their Clinical Appropriateness Guidelines for Diagnostic Coronary Angiography. These new updates, effective for dates of service on or after March 13, 2022, affect most Independence Commercial and Medicare Advantage HMO and PPO members.

For detailed information on AIM's revised guidelines, please read:

• Commercial Medical Policy #11.02.27e: Percutaneous Coronary Intervention, Coronary Angiography and Arterial Ultrasound
• Medicare Advantage Medical Policy #MA11.113e: Percutaneous Coronary Intervention, Coronary Angiography and Arterial Ultrasound